4D Molecular Therapeutics Inc (NASDAQ: FDMT) announced updated interim safety and efficacy data from the two 4D-310 INGLAXA Phase 1/2 trials for Fabry disease cardiomyopathy. All three patients ...

By: Johan Potgieter - Cluster Industrial Software Lead at Schneider Electric What is machine vision? By definition, it allows automated systems to “see” the real world; an ocular implant for machines, ...

A series of LCD displays modules that support the Raspberry Pi family of single computers has been announced by 4D Systems. The gen4-4DPI series is available in three screen sizes: 4.3, 5.0 and 7 ...

The 4D solution will now be integrated into IRIS.TV’s video data marketplace, which brings together video and CTV publishers, contextual data partners, ad servers, and SSPs so publishers’ video ...

Information coming from the acquisition PC, such as retention time, ion mobility, precursor m/z and fragment ion spectra, is all sent to PaSER and processed in real-time.Database search results ...

Monday, 4D Molecular Therapeutics FDMT released interim data from the Phase 2 PRISM clinical trial evaluating intravitreal 4D-150 in wet age-related macular degeneration (wet AMD) patients. A ...

4D Molecular Therapeutics also announced that interim clinical data from cohort 1 of this Phase 1/2 clinical trial will be released at 7:30 am E.T., on Monday, November 14, 2022. 4D will host a ...

Data Sheets. Podcast. Markets. ... a 77-GHz, 4D digital imaging radar-on-chip. With the device's launch in 2022, ... Nixie Tube Display Power Solution Brings Retro Charm to Any Project.

The Dynamic Data Indexer (DDI) feature adds SOAP-based Web Services client support to the 4D WebSTAR Search crawler. This allows dynamic data to be searched rapidly by any Web Services-compliant ...